Market Data Forecast Says Alzheimer's Disease Therapeutics and Diagnostics Market Expects Huge Growth in Future Owing to Growing Old Age Population - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
January 22, 2018 Newswires
Share
Share
Post
Email

Market Data Forecast Says Alzheimer’s Disease Therapeutics and Diagnostics Market Expects Huge Growth in Future Owing to Growing Old Age Population

ReleaseWire

Hyderabad, India -- (SBWIRE) -- 01/22/2018 -- According to a new market research report " Alzheimer's Disease Therapeutics and Diagnostics Market by Therapeutics (Marketed Drugs-(NMDA Receptor Antagonists, Cholinesterase Inhibitors), Pipeline Drugs), and by Diagnostics (Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others) - Global Forecast to 2021", published by Market Data Forecast™, the market is expected to reach USD 14.43 billion by 2021 from USD 9.97 billion in 2016, at a CAGR of 6.5%. Factors driving the growth of this market include growing old age population, rising R&D investment, high frequency of Alzheimer's and neurodegenerative diseases, and improved life expectancy of the general population.

Browse Market Data Tables and Figures spread through 178 Pages and in-depth TOC on "Alzheimer's Disease Therapeutics and Diagnostics "
https://www.marketdataforecast.com/market-reports/global-alzheimers-disease-therapeutics-and-diagnostics-market-2247/
Early buyers will receive 10% customization on this report

Discuss the opportunities of the market
Marketed Drugs are estimated to account for the largest market share in 2016

On the basis of Therapeutics is segmented into Marketed Drugs and Pipeline Drugs. Marketed Drugs are further segmented into NMDA Receptor Antagonists and Cholinesterase Inhibitors. Marketed Drugs lead the global market on the basis of Therapeutics due to a large user base.

Customized Report: https://www.marketdataforecast.com/market-reports/global-alzheimers-disease-
therapeutics-and-diagnostics-market-2247/customize-report

On the basis of Diagnostics, the global Alzheimer's disease Therapeutics and Diagnostics market is segmented into Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. .

Inquire: https://www.marketdataforecast.com/market-reports/global-alzheimers-disease-therapeutics-and-diagnostics-market-2247/request-sample

North America is estimated to command the largest share of the market
Based on region, the Alzheimer's disease Therapeutics and Diagnostics Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the Alzheimer's Disease Therapeutics and Diagnostics Market in 2016. This is attributed to factors such as due to the growing prevalence of Alzheimer's disease and extensive technological developments in the region as compared to other regions.

Key players in the Alzheimer's Disease Therapeutics and Diagnostics Market include Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG, Amarantus Bioscience Holdings, H. Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals, Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F. Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals etc.

The scope of the report provides:

The evaluation of the current market for your product or services and the future implications of the market

Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future

Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment

Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share

The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter's Five Forces

The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments

Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.

Browse Related Reports

Cardiac Assist Devices Market by Type {Ventricular Assist Devices (VAD), Intra-Aortic Balloon Pumps (IABP) & Total Artificial Heart (TAH)}, and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2017 – 2022)
https://www.marketdataforecast.com/market-reports/global-cardiac-assist-devices-market-25/

Patient Monitoring Market by Application (Neurology, Hemodynamic, cardiac, Fetal and neonatal, Respiratory, Multi parameter, remote patient monitors, Temperature monitors and Weight monitoring systems), and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2017 – 2022)
https://www.marketdataforecast.com/market-reports/global-patient-monitoring-market-135/

Hybrid MRI Systems Market by Field Strength (Low -to mid -Field, High Field, Very High Field, Ultra High Field) by Type (X-Ray/MRI, PET/MRI, Radiography/MRI, MPI/MRI) & Application (Brain, Pelvic, Cardiac, Abdominal, Musculoskeletal) and by Region – Global Industry Analysis, Share, Size, Growth, Trends, and Forecasts (2016-2021)
https://www.marketdataforecast.com/market-reports/global-hybrid-mri-systems-market-2489/

Contact Info:
Name: Mr. Abhishek Shukla Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

For more information on this press release visit: http://www.sbwire.com/press-releases/market-data-forecast-says-alzheimers-disease-therapeutics-and-diagnostics-market-expects-huge-growth-in-future-owing-to-growing-old-age-population-919662.htm

Media Relations Contact

Sai Kutumbarao
Business Development Executive
Market Data Forecast
Telephone: 888-702-9626
Email: Click to Email Sai Kutumbarao
Web: http://www.marketdataforecast.com/

Older

A.M. Best Comments on Credit Ratings of American International Group, Inc. Following Announced Transaction

Newer

InfraREIT Announces Tax Characterization and Other Tax Reporting Information for 2017 Distributions

Advisor News

  • When new investment trends emerge, Gen Z is most likely generation to be first in
  • Could ‘plain English’ become an advisor’s secret weapon?
  • IRI urges Senate action on 403(b) parity legislation
  • Three estate planning ideas to protect your clients and their wealth
  • What advisors must know about accessible client documents
More Advisor News

Annuity News

  • NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
  • NAIC working group pressed to accelerate annuity illustration overhaul
  • State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
  • Wink: Annuity sales post strong Q2, led by MYGAs and structured products
  • Legacy Marketing Group partners with Malibu Life USA for annuity launch
More Annuity News

Health/Employee Benefits News

  • New Data from Zhejiang University Illuminate Findings in Science (Does long-term care insurance affect labor supply? Empirical evidence from China): Science
  • CT Sues Trump Administration Over Medicaid Funds For Gender-Affirming Care
  • Data on Diabetes Research Described by Jeff Romine et al (Insurance-Provided Grocery Assistance and Health Care Outcomes Among Patients With Diabetes): Diabetes Research
  • Recent Findings from Hackensack Meridian School of Medicine Advance Knowledge in Mental Health Diseases and Conditions (AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression): Mental Health Diseases and Conditions
  • AM Best Affirms Credit Ratings of Sammons Financial Group, Inc. and Its Subsidiaries
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Do You Qualify for Any of September's Class Action Settlements?
  • AM Best Affirms Credit Ratings of Sammons Financial Group, Inc. and Its Subsidiaries
  • NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
  • DLA Piper adds former NAIC CEO Gary Anderson to its Insurance practice
  • Security Benefit Extends Sponsorship of Professional Golfer Gary Woodland Through 2030
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
  • MassMutual Ascend Surpasses $2 Billion in Lifetime Advisory Annuity Sales, Reflecting Continued Momentum in RIA Channel
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.